Clinical Trials Logo

Fibroid clinical trials

View clinical trials related to Fibroid.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06143631 Recruiting - Leiomyoma Clinical Trials

Prescription of Letrozole for Uterine Myoma

PLUM
Start date: June 14, 2024
Phase: Phase 4
Study type: Interventional

The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.

NCT ID: NCT06135870 Recruiting - Leiomyoma Clinical Trials

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

SOUL
Start date: November 1, 2023
Phase:
Study type: Observational

The investigators are evaluating the role of senescent cells in uterine fibroids.

NCT ID: NCT03784976 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis

Start date: July 3, 2018
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to look at the effectiveness of prescribing yoga classes to patients with dysmenorrhea (irregular or painful periods), or other menstrual disorders on patients' self reported pain and quality of life. Patients will be recruited from primary care clinics around Illinois, including Carle Hospital. This is a randomized trial in which patients will first be randomized into the control or intervention group. Patients in the control group will undergo usual care and be surveyed at baseline, 3 months, 6 months and 9 months. Patients in the control group will be offered the 3 months of yoga therapy complimentary after completing the 9 month control. Control patients who choose to participate in the yoga therapy will be asked to also complete the surveys at the end of the 3 month yoga intervention. Patients in the intervention group will first undergo 3 months of regular care and then 3 months of biweekly yoga classes. Participants will complete surveys at baseline, 3 months (after of control care), 6 months (after 3 months of biweekly yoga classes), 9 months, and 12 months (after 6 months of observation and optional yoga practice).

NCT ID: NCT03143114 Recruiting - Infertility Clinical Trials

Effect of Myomectomy for Intramural Myoma on Fertility Outcomes in Infertile Women

Start date: May 15, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of myomectomy for intramural myomas on the fertility outcomes in infertile women.

NCT ID: NCT02361905 Recruiting - Fibroid Clinical Trials

Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas

Start date: February 2015
Phase: Phase 4
Study type: Interventional

Cellular leiomyomas (CLs) are described as leiomyomas that are significantly more cellular than the surrounding myometrium, often with crowding and overlapping of nuclei. they often are soft and appear more tan or yellow and less circumscribed than the usual leiomyomas. Pre-operatively CLs can be recognized at ultrasound evaluation because they appear as hypoechoic uterine lesions. patients with hypoechoic myoma have a significantly longer surgery time after treatment with a gonadotropin-releasing hormone (GnRH) analog probably related to degenerative changes induced by this treatment. Hypoechoic CLs should be more responsive to ulipristal acetate treatment than common leiomyomas. The antiproliferative ulipristal effect, moreover, induces a condition of apoptotic necrosis that, compared to GnRH-a myxoid necrosis, probably allows an easier surgical enucleation of the tumor.

NCT ID: NCT02361879 Recruiting - Fibroid Clinical Trials

Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma

Start date: February 2015
Phase: Phase 4
Study type: Interventional

The uterine leiomyoma is the most common female benign disease. Submucosal fibroid are about 10%, they distort the endometrial cavity causing heavy and/or irregular bleeding (AUB) and infertility. Hysteroscopic removal of submucosal myomas improves this conditions. GnRH analogues are commonly used before hysteroscopic myomectomy to make surgery easier and safer, but they are expensive, have potential side effects and lack a robust evidence base to support this practice. Ulipristal acetate treatment was able and faster to control in 90% of cases uterine bleeding associated with fibroids than GnRH agonists. UPA significantly improved quality of life and pain reduction.

NCT ID: NCT02357563 Recruiting - Fibroid Clinical Trials

Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation

Start date: February 2015
Phase: Phase 4
Study type: Interventional

Submucosal fibroid grow inside the uterine cavity and are associated with menorrhagia, abnormal uterine bleeding (AUB) and infertility. Type II (G2) fibroids often require more surgeries due to their particular position in the myometrium. Surgery, moreover, should always be tailored, particularly in patients wishing to conceive, to preserve the integrity of the myometrium. Preoperative use of GnRH agonist appears to be relevant and beneficial in patients with submucous fibroids, but are associated with several side effects. the eighty percent of patients treated by UPA showed a clinically meaningful reduction of more than 25% in fibroid volume, and 50% of patients a reduction of 50%. fibroid volume reduction appeared to be maintained for 6 months after the end of UPA treatment

NCT ID: NCT00323999 Recruiting - Menorrhagia Clinical Trials

Hysteroscopic Monopolar and Bipolar Resection

Start date: December 2004
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate bipolar equipment versus monopolar, and to see if there is any differences between the two types of bipolar equipment espescially regading both safety and effect.